Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 321 - 328 of 11618 results
MBTA's $1B Deal Refunds BABs, Addresses FTA Safety Concerns
July 8, 2024| News
GPs are cooking up a PE exit recovery
July 5, 2024| News
A First-of-its-Kind Telemedicine Criminal Prosecution: Key Takeaways
July 3, 2024| Blog| Viewpoint
Six Agencies Finalize Rule on Safeguards for AI Real Estate Valuation Models — AI: The Washington Report
July 3, 2024| Article| Viewpoint
A New Chapter in California’s Ongoing PAGA is Lava Saga: PAGA Reform
July 3, 2024| Blog| Viewpoint
Revived Skinny Label Case Is A Warning For Generics
July 3, 2024| News
Acing Your First Start-up Board Meeting: Board Deck Tips
July 2, 2024| Alert| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.